P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins

• F Muller,
• F Gsottberger,
• S Petkovic,
• L Nitschke,
• A Mackensen,
• K Wendland

Affiliations

F Muller

University Hospital of Erlangen, Erlangen, Germany

F Gsottberger

1University Hospital of Erlangen, Erlangen, Germany

S Petkovic

University Hospital of Erlangen, Erlangen, Germany

L Nitschke

2University of Erlangen, Erlangen, Germany

A Mackensen

1University Hospital of Erlangen, Erlangen, Germany

K Wendland

Universitätsklinukum Erlangen, Erlangen, Germany